GlaxoSmithKline Lands $342M Army Vaccine Procurement Contract

GlaxoSmithKline Lands $342M Army Vaccine Procurement Contract
vaccine

Pharmaceutical company GlaxoSmithKline has been awarded a $342M contract by the U.S. Army to obtain COVID-19 vaccines in mass quantities from multiple vendors.

The service branch obligated the full contract amount at the time of award to support coronavirus response efforts at military sites within and outside the continental U.S., the Department of Defense said Thursday.

Army Contracting Command received one bid for the procurement.

Contract work will take place at Research Triangle Park in North Carolina through Feb. 28, 2021.

Check Also

Savannah River Site

DOE Issues RFI for Savannah River Site Nuclear Cleanup Effort

The Department of Energy is looking for potential sources of environmental remediation services at the Savannah River Site in South Carolina to support the National Nuclear Security Administration's site cleanup and modernization programs. 

Alain Bellemare Operating Executive Carlyle

Alain Bellemare Named Operating Executive for Carlyle’s Global Aerospace, Defense, Gov’t Services

Alain Bellemare, an aerospace industry veteran, has been appointed an operating executive within the global aerospace, defense and government services group at The Carlyle Group (Nasdaq: CG).